临床高危青少年听觉偏差失匹配负波与未来精神病风险
该研究基于北美前驱期纵向研究(NAPLS-2)多中心数据,分析临床高危精神病(CHR-P)青少年基线失匹配负波(MMN)波幅及其与24个月结局的关系。结论认为MMN缺陷对转化敏感但关联幅度有限,可能为多变量预测算法提供附加风险信息。
要点
- CHR-P未来转化者基线MMN波幅较未转化者减低(全样本d=0.27,未服药亚组d=0.33)。
- MMN单独作为精神病发作生物标志物的前景有限,或可为多变量预测算法提供附加风险信息。
核心结论
- 本研究发现CHR-P个体基线MMN波幅缺陷对未来精神病转化敏感,尤其在基线未服用抗精神病药者中,但关联幅度有限。
- MMN单独作为精神病发作生物标志物的前景有限,可能为多变量预测算法提供附加风险信息,并作为高危亚组新型治疗开发的转化神经生理靶点。
研究设计与样本
- 多中心病例对照研究,数据来自北美前驱期纵向研究(NAPLS-2)的8个大学附属门诊研究项目。
- 基线MMN数据采集于2009年6月至2013年4月,临床结局随访24个月。
- CHR-P组n=580(平均[SD]年龄19.24[4.39]岁,女性247例占42.6%),健康对照组n=241(平均年龄20.33[4.74]岁,女性114例占47.3%)。
- 采用被动听觉oddball范式记录脑电图,测量由时长、音高及时长+音高双偏差音诱发的MMN。
主要发现
- 未来转化为精神病者(n=77,未服药n=54)基线MMN波幅较未转化者(n=238,未服药n=190)减低,全样本d=0.27,未服药亚组d=0.33。
- 全样本中基线用药状态与组别及偏差类型存在交互作用,未服药转化者较未服药未转化者双偏差MMN较单偏差减低(d=0.43)。
关键数值与推荐
- MMN波幅为被动听觉oddball范式下时长、音高及时长+音高双偏差音诱发的失匹配负波。
临床怎么用
- MMN波幅缺陷或可为CHR-P个体未来精神病转化风险提供参考信息,尤其对基线未服用抗精神病药者。
- MMN单独预测精神病发作的价值有限,可能作为多变量预测算法的补充指标。
局限性
- 原文未述局限性
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
IMPORTANCE: Although clinical criteria for identifying youth at risk for psychosis have been validated, they are not sufficiently accurate for predicting outcomes to inform major treatment decisions. The identification of biomarkers may improve outcome prediction among individuals at clinical high risk for psychosis (CHR-P). OBJECTIVE: To examine whether mismatch negativity (MMN) event-related potential amplitude, which is deficient in schizophrenia, is reduced in young people with the CHR-P syndrome and associated with outcomes, accounting for effects of antipsychotic medication use. DESIGN, SETTING, AND PARTICIPANTS: MMN data were collected as part of the multisite case-control North American Prodrome Longitudinal Study (NAPLS-2) from 8 university-based outpatient research programs. Baseline MMN data were collected from June 2009 through April 2013. Clinical outcomes were assessed throughout 24 months. Participants were individuals with the CHR-P syndrome and healthy controls with MMN data. Participants with the CHR-P syndrome who developed psychosis (ie, converters) were compared with those who did not develop psychosis (ie, nonconverters) who were followed up for 24 months. Analysis took place between December 2019 and December 2021. MAIN OUTCOMES AND MEASURES: Electroencephalography was recorded during a passive auditory oddball paradigm. MMN elicited by duration-, pitch-, and duration + pitch double-deviant tones was measured. RESULTS: The CHR-P group (n = 580; mean [SD] age, 19.24 [4.39] years) included 247 female individuals (42.6%) and the healthy control group (n = 241; mean age, 20.33 [4.74] years) included 114 female individuals (47.3%). In the CHR-P group, 450 (77.6%) were not taking antipsychotic medication at baseline. Baseline MMN amplitudes, irrespective of deviant type, were deficient in future CHR-P converters to psychosis (n = 77, unmedicated n = 54) compared with nonconverters (n = 238, unmedicated n = 190) in both the full sample (d = 0.27) and the unmedicated subsample (d = 0.33). In the full sample, baseline medication status interacted with group and deviant type indicating that double-deviant MMN, compared with single deviants, was reduced in unmedicated converters compared with nonconverters (d = 0.43). Further, within the unmedicated subsample, deficits in double-deviant MMN were most strongly associated with earlier conversion to psychosis (hazard ratio, 1.40 [95% CI, 1.03-1.90]; P = .03], which persisted over and above positive symptom severity. CONCLUSIONS AND RELEVANCE: This study found that MMN amplitude deficits were sensitive to future psychosis conversion among individuals at risk of CHR-P, particularly those not taking antipsychotic medication at baseline, although associations were modest. While MMN shows limited promise as a biomarker of psychosis onset on its own, it may contribute novel risk information to multivariate prediction algorithms and serve as a translational neurophysiological target for novel treatment development in a subgroup of at-risk individuals.
引用
- Hamilton HK, Roach BJ, Bachman PM, et al. Mismatch Negativity in Response to Auditory Deviance and Risk for Future Psychosis in Youth at Clinical High Risk for Psychosis. JAMA Psychiatry. 2022. PMID: 35675082. doi:10.1001/jamapsychiatry.2022.1417
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。